Health Technology Assessment and Market Access
Market access, pricing and reimbursement strategic planning
Health Technology Assessment (HTA) is a systematic evaluation process that examines the clinical, economic, and social implications of health interventions. By synthesising scientific evidence, HTAs help stakeholders—including government bodies, healthcare providers, and pharmaceutical companies—make informed decisions about adopting new technologies.
Our offering includes
- Evidence gap analysis
- Therapeutic positioning
- Evidence based analysis (unmeet medical need)
- Global Value Dossier (GVD)
- Reimbursement dossier and support the submission to HTA agencies
- GVD local adaptation
- Pre-submission support, including discussion of PICO proposed by HTA agencies
- Post-submission support, including assessment discussion with HTA agencies
- Assessment of the feasibility of early market access
Contact Us
FAQ
Frequently Asked Questions
Health Technology Assessment (HTA) is a systematic evaluation process that analyses the clinical, economic, and social implications of health interventions. It plays a critical role in healthcare decision-making, guiding stakeholders—including government bodies, healthcare providers, and pharmaceutical companies—on whether to adopt new technologies. By assessing factors such as clinical effectiveness, safety, and cost-effectiveness, HTAs help ensure that patients receive the best possible care while optimising resource allocation.
At Clevidence, our HTA process follows a rigorous, multi-step methodology designed to deliver reliable, evidence-based results. We begin with a comprehensive systematic literature review to gather data on the clinical efficacy and safety of the intervention. This is followed by economic modelling, where we evaluate the cost-effectiveness using techniques like cost-utility analysis and budget impact analysis. Finally, we engage key stakeholders to ensure our findings are aligned with practical, real-world needs. This structured approach guarantees high-quality, actionable insights for our clients.
Real-World Applications of Our HTA Expertise
Optimising Market Entry for an Innovative Treatment.
Clevidence conducted a comprehensive HTA that supported a major pharmaceutical company in securing reimbursement approval, leading to expedited market access.
The client achieved faster integration into healthcare systems, benefiting both patients and stakeholders.
